Encephalopathies: Zerlyn T. Leonardo, M.D., FPCP, FPNA

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 50

Encephalopathies

Zerlyn T. Leonardo, M.D., FPCP, FPNA


Encephalopathy
• Acquired diffuse disturbance of cerebral
function due to failure of some other
organ system
 Heart /Circulation
 Lung/Respiration
 Kidneys
 Liver
 Endocrine glands
Encephalopathies
1. Hypoxic-Ischemic Encephalopathy
2. Delayed Post-anoxic Encephalopathy
3. Metabolic Encephalopathy
4. Septic Encephalopathy
5. Wernicke’s Encephalopathy
Hypoxic-Ischemic Encephalopathy
(HIE)
Hypoxic-Ischemic Encephalopathy

• Due to lack of Oxygen delivery to the


brain secondary to:
 Respiratory Failure (Hypoxia)
• Asphyxiation, paralysis of respiration, carbon
monoxide or cyanide poisoning
 Hypotension (Ischemia)
• Myocardial infarction, cardiac arrest, shock
HIE: Clinical Manifestation

Reversible --------------------------------Irreversible

Impaired judgment, Persistent coma or


Inattentiveness, vegetative state,
Motor incoordination, Dementia,
Euphoria Visual agnosia ,
Parkinsonism,
Choreoathetosis,
Cerebellar ataxia,
Myoclonus,
Seizures,
Amnestic state
HIE: Clinical Manifestation

Reversible --------------------------------Irreversible

Duration of hypoxia or ischemia?


Rapidity of change of PaO2?
Rule of thumb:
•Hypoxia/Ischemia > 3-5 min
 Expect some degree of Permanent Brain Damage
•Gradual decrease in PaO2  better tolerated
HIE: Pathology
HIE secondary to hypoxia
• Brain cells most vulnerable to hypoxia
1. Hippocampal pyramidal cells of CA1
2. Layers 3 and 5 of the Neocortex
3. Purkinje cells
4. Striatal neurons (basal ganglia)
HIE: Pathology
• Hippocampal
CA1 Atrophy

Amnestic state,
Dementia
HIE: Pathology
HIE secondary to hypoxia
• Brain cells most vulnerable to hypoxia
1. Hippocampal pyramidal cells of CA1
2. Layers 3 and 5 of the Neocortex
3. Purkinje cells
4. Striatal neurons (basal ganglia)
HIE: Pathology
• Laminar Necrosis

Inattention, Dementia, Poor judgment


HIE: Pathology

• Laminar Necrosis
HIE: Pathology
HIE secondary to hypoxia
• Brain cells most vulnerable to hypoxia
1. Hippocampal pyramidal cells of CA1
2. Layers 3 and 5 of the Neocortex
3. Purkinje cells
4. Striatal neurons (basal ganglia)
HIE: Pathology
• Purkinje cell death

Cerebellar Ataxia
Motor Incoordination
HIE: Pathology
HIE secondary to hypoxia
• Brain cells most vulnerable to hypoxia
1. Hippocampal pyramidal cells of CA1
2. Layers 3 and 5 of the Neocortex
3. Purkinje cells
4. Striatal neurons (basal ganglia)
HIE: Pathology
• Striatal Neuronal
death

Parkinsonism
Choreoathetosis
HIE: Pathology
• HIE secondary to hypotension
 Result in Watershed Infarction
HIE: Pathology

• HIE secondary to
hypotension
 Result in Watershed
Infarction

Visual Agnosia,
“Man-in-a-barrel” weakness
HIE: Diagnosis
• Hx of hypoxic-ischemic event
 Cardiac Arrest
 Blood pressure < 70 mmHg systolic or
PaO2 < 40 mmHg, and the duration
• Elevated CarboxyHb level + Cherry Red
skin color
 Carbon monoxide intoxication  hypoxia
HIE: Treatment
• Restore normal cardiorespiratory
function
• Hypothermia to target Temp of 32-34°C
for 12-24 hours
• Hyperbaric Oxygen for CO intoxication
• Anticonvulsants for myoclonic seizures
 Clonazepam 1.5-10 mg daily
 Valproate 300-1200 mg daily
HIE: Prognosis

• For comatose survivors of


cardiopulmonary resuscitation (CPR)
 Rule out confounders first:
• Usage of Sedative
• Usage of Neuromuscular blocking agents
• Hypothermia therapy
• Organ failure or shock
Delayed Post-anoxic Encephalopathy
Delayed Post-anoxic Encephalopathy

• Uncommon phenomenon
 Patients with CO and Cyanide intoxication
• No evident clinical impairment initially
• Develop parkinsonian features (akinesia and
rigidity but without tremors)
 Patients initially recovering from a hypoxic-
ischemic event develop a relapse
• Apathy, confusion, agitation
Delayed Post-anoxic Encephalopathy
• Progressive neurologic deficits
 shuffling gait, diffuse rigidity and spasticity
 persistent parkinsonism or myoclonus
• Occasionally  coma and death after 1–2
weeks
• Pathology:
 Widespread cerebral demyelination may be
present
 Damage to the basal ganglia
Delayed Post-anoxic Encephalopathy
Metabolic Encephalopathy
Metabolic Encephalopathy
• Disorders of cerebral function due to:
 Vital organ failure (liver, kidney)
 Electrolyte imbalances (sodium)
 Hypoglycemia
 Hyperglycemia
 Endocrine disorders (Thyroid storm,
Myxedema, SIADH, Hashimoto, DI)
Metabolic Encephalopathy:
Clinical Manifestation
• Varies:
 Mild confusional state  deep coma with
decerebrate posturing
• Delirium or acute confusional state
 usually the earliest recognized brain malfunction
 Patients may be:
• agitated, usually with increased sympathetic nervous
system activity, or
• quiet and withdrawn
Metabolic Encephalopathy:
Diagnosis
• Clues:
 Background of vital organ dysfunction or
history of some event, e.g. toxic exposure
that would upset the metabolic milieu of the
brain
 Time course of symptoms:
• Acute or recent in onset
• Fluctuating level of consciousness
• Coherent and obeying at one point, and a few hours
later in a stupor
Metabolic Encephalopathy:
Diagnosis
• Clues:
 PE: Jaundice, hyperventilation, tremors,
asterixis, multifocal myoclonus
 Neuro exam:
• Cranial nerve reflexes generally spared except
in Wernicke’s encephalopathy (affects
vestibuloocular reflex)
Metabolic Encephalopathy:
Treatment
• Treat the underlying problem
• Low dose neuroleptics for severe
agitation
Septic Encephalopathy
Septic Encephalopathy:
Pathophysiology
Sepsis

• Action of • Reduced cerebral


inflammatory blood flow and
mediators on the oxygen extraction by
cerebrovascular the brain
endothelium • Cerebral edema
• Impaired astrocyte • Disruption of the
blood-brain barrier
function

Multiorgan
Failure Septic Encephalopathy
Septic Encephalopathy: Diagnosis

• Background of sepsis + encephalopathy


(diffuse brain dysfunction without focal
findings)
 Varies from acute confusional state to
coma
 Fluctuating level of consciousness
 Abnormal movements like tremors,
asterixis and myoclonus
Septic Encephalopathy: Diagnosis

• Patients dying from severe sepsis or


septic shock may have:
 elevated levels of the serum brain injury
biomarker S-100
 neuropathologic findings of neuronal
apoptosis and cerebral ischemic injury
Septic Encephalopathy: Prognosis

• Septic encephalopathy presenting as


coma  50% mortality rate
• Successful treatment of underlying
sepsis almost always result in complete
resolution of encephalopathy
• Profound long-term cognitive disability
is uncommon
Wernicke’s Encephalopathy
Wernicke’s Encephalopathy
• Due to Thiamine (Vit B1) deficiency
 Alcoholism
 Malnutrition due to:
• hyperemesis, starvation, renal dialysis, cancer, AIDS, or
rarely gastric surgery
• Characteristic triad:
 Confusion
 Ophthalmoplegia all 3 present only in 1/3 of
 Ataxia patients
Wernicke’s Encephalopathy
• If untreated:
 stupor  coma  death
• If treated:
 Ocular palsies improve within hours of thiamine
administration
• Horizontal nystagmus may persist
 Ataxia improves more slowly
• ½ recover incompletely (persist as wide-based, shuffling
gait, unable to tandem walk)
 Confusion improve more gradually
Wernicke’s Encephalopathy
• With treatment  confusion recede  an
amnestic state with impairment in recent
memory and learning may become more
apparent (Korsakoff's psychosis)
• Korsakoff's psychosis
 frequently persistent
 characterized by:
• Gaps in memory
• Confabulation
• Disordered temporal sequencing
Wernicke’s Encephalopathy:
Pathology
• Endothelial proliferation, demyelination, and some
neuronal loss
Acute cases
 Periventricular lesions surround the third ventricle, aqueduct,
and fourth ventricle, with petechial hemorrhages
Chronic cases
 Atrophy of the mamillary bodies
• These changes may be detected by MRI scanning
• Amnestic defect is related to lesions in the dorsal
medial nuclei of the thalamus
Wernicke’s Encephalopathy:
Pathogenesis
• Thiamine
 Enzyme co-factor in glucose and glutamate
metabolism
 Deficiency produces
• Diffuse decrease in cerebral glucose utilization
and results in mitochondrial damage
• Excitotoxic cell damage due to glutamate
accumulation
Wernicke’s Encephalopathy:
Treatment
• Thiamine 100mg IV or IM ASAP then
daily until normal diet is resumed
 Given before IV glucose solutions are
started
Central Pontine Myelinolysis
Central Pontine Myelinolysis
• Typically presents as quadriplegia and
pseudobulbar palsy
• Predisposing factors
 severe underlying medical illness or
nutritional deficiency
 most cases are associated with rapid
correction of hyponatremia or with
hyperosmolar states
Central Pontine Myelinolysis:
Pathology
• Demyelination without inflammation in
the base of the pons, with relative
sparing of axons and nerve cells
• Occasionally present as lesions outside
the brainstem
Central Pontine Myelinolysis:
Prevention
• Therapeutic guidelines for the
restoration of severe hyponatremia
should aim for gradual correction
 10 mmol/L (10 meq/L) within 24 h
 20 mmol/L (20 meq/L) within 48 h

You might also like